Cited Evidence on Etiologies and Pathophysiology of Chronic Respiratory Failure

Neuromuscular and Chest‑Wall Disorders

Progressive ventilatory pump failure is characteristic of amyotrophic lateral sclerosis, muscular dystrophy, myasthenia gravis, and acid maltase deficiency, with diaphragm involvement often preceding limb weakness. 1
Severe chest‑wall deformities such as scoliosis or post‑thoracoplasty restrict lung expansion, lower ventilatory capacity, and increase the work of breathing, producing chronic hypoventilation. 1

Chronic lung disease of infancy—including bronchopulmonary dysplasia—produces abnormal lung mechanics, air‑trapping, and persistent hypoxemia. 2

Weakness and fatigue of the respiratory muscles impair the ability to sustain adequate minute ventilation, leading to chronic respiratory failure. 2

Gastro‑esophageal reflux and swallowing dysfunction cause recurrent aspiration, pulmonary inflammation, and chronic hypoxemia. 2
Pulmonary hyperinflation alters diaphragmatic geometry and lowers esophageal sphincter tone, perpetuating the aspiration cycle. 2
Malnutrition delays lung growth, weakens respiratory muscles, and increases susceptibility to diaphragmatic fatigue. 2

Chronic pulmonary hypertension raises right‑ventricular afterload through hypoxic vasoconstriction, vascular remodeling, and elevated pulmonary vascular resistance. 3
An “out‑of‑proportion” pulmonary hypertension phenotype (mean pulmonary artery pressure > 40 mmHg) requires distinct management strategies. 4

Expiratory airflow obstruction and dynamic hyperinflation increase the work of breathing, intensifying dyspnea and limiting exercise capacity. 3
Respiratory muscle dysfunction arises from inactivity‑induced deconditioning, systemic inflammation, oxidative stress, blood‑gas disturbances, and chronic corticosteroid exposure. 3

Right‑ventricular hypertrophy and failure secondary to chronic pulmonary hypertension impair left‑ventricular filling via septal shift. 3
Cardiovascular disease accounts for 26 % of deaths among patients with moderate‑to‑severe COPD. 4

Lower‑limb skeletal muscle alterations are common in chronic respiratory disease, rendering muscles more prone to contractile fatigue. 3
Elevated lactate production at given exercise workloads contributes to exercise limitation and increased ventilatory demand. 3

Chronic airway infection, mucus plugging, and progressive bronchiectasis in cystic fibrosis cause combined ventilatory failure and gas‑exchange abnormalities. 1

Emphysema‑related pulmonary hyperinflation produces severe ventilation‑perfusion mismatch (hypoxemia) together with dynamic hyperinflation (hypercapnia). 4

The American Thoracic Society suggests that Acute Respiratory Distress Syndrome (ARDS) represents the most severe form of acute lung injury, characterized by bilateral pulmonary infiltrates, increased pulmonary vascular permeability, and severe hypoxemia with mortality remaining 30-40% despite advances in care 5
ARDS is triggered by diverse insults including sepsis, pneumonia, aspiration, trauma, and pancreatitis, and is classified by severity: mild (PaO₂/FiO₂ 200-300 mmHg), moderate (100-200 mmHg), or severe (≤100 mmHg) 5
Community-acquired and hospital-acquired pneumonia cause alveolar filling with inflammatory exudate, creating intrapulmonary shunting where blood bypasses ventilated alveoli entirely, and severe childhood respiratory infections are associated with reduced lung function and increased respiratory symptoms in adulthood 5, 6

The European Respiratory Society notes that COPD exacerbations account for the majority of Type 2 respiratory failures, and tobacco smoke is the major risk factor worldwide, though biomass cooking and heating in poorly ventilated dwellings also contribute 5, 6, 7
Asthma may be a risk for development of chronic airflow limitation and COPD, and HIV infection accelerates onset of smoking-related emphysema and COPD 6, 8
The American College of Chest Physicians states that dynamic hyperinflation prevents expiration to relaxation volume, creating intrinsic PEEP (PEEPi) that acts as an inspiratory threshold load, and severe V/Q abnormalities worsen during acute exacerbations 5, 9, 10

The American Journal of Respiratory and Critical Care Medicine reports that concomitant chronic diseases occur frequently in COPD patients and independently affect mortality and hospitalizations, and cardiovascular disease accounts for 26% of deaths in moderate-to-severe COPD 6, 8, 10
Airway hyperresponsiveness is an independent predictor of COPD and respiratory mortality in population studies, and may indicate risk for excessive lung function decline in mild COPD 6

The American Thoracic Society recommends that spirometry is required to make the diagnosis of COPD; post-bronchodilator FEV₁/FVC <0.70 confirms persistent airflow limitation, and arterial blood gas analysis distinguishes Type 1 (PaO₂ <8 kPa with normal/low PaCO₂) from Type 2 (PaCO₂ >6 kPa) 5, 6, 8, 9